Genebox raises Series B extension to scale gene-chip business

What's the deal? Genebox, a Chinese gene-testing company, has closed a Series B extension round, announced in July 2026. The round brought in new investors Zhaoken Capital and Guizhou Venture CapitalDealroom has a profile for this one. Try Dealroom →.

What does the company do? Genebox develops gene-chip technology in-house and runs the full chain from chip research and production to testing services. Its business spans pet genetic testing, agricultural molecular breeding, and medical diagnostics.

What's the endgame? The company says its self-developed core technology breaks the technical monopoly held by firms in Europe and the US. It plans to use the new funding for research and development and to expand into international markets.

The signal: The backing from Zhaoken Capital and Guizhou Venture Capital points to continued domestic support for Chinese biotech firms building homegrown alternatives to Western-controlled gene-chip technology.

Image credit: Centers for Disease Control and Prevention